crataegus monogyna powder은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

crataegus monogyna powder은 임신 중 안전한가요?

No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for Crataegus monogyna powder. Peer‑reviewed literature on hawthorn relates mainly to cardiovascular pharmacology; there is no clear human teratogen signal or regulatory H360/H361 flags. Topical cosmetic use is expected to give negligible systemic exposure based on typical use patterns.

crataegus monogyna powder은 모유 수유 중 안전한가요?

No regulatory (ECHA Annex VI), CIR or SCCS contraindication for lactation, and no peer‑reviewed evidence of specific lactation/infant toxicity from topical cosmetic use. Systemic transfer via breastmilk would require significant maternal systemic exposure, which is unlikely from cosmetic topical application.

crataegus monogyna powder은 아기 피부에 안전한가요?

No evidence of developmental or reproductive hazard specific to infants. However, because infant skin has a higher surface‑area:weight and a less mature barrier, a small increase in potential exposure is prudent (exposure score +1). There is no infant‑specific mechanistic evidence to raise hazard or mechanism scores.

VeriMom은 crataegus monogyna powder을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 crataegus monogyna powder을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 crataegus monogyna powder 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.